PER 5.71% 9.9¢ percheron therapeutics limited

Ann: ATL1103 Phase II Trial - Successful Efficacy Results, page-67

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 14,981 Posts.
    lightbulb Created with Sketch. 51
    Just ridiculous, let's hope there's been too many ST holders in here for a quick buck keeping it from running.
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.